Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    The Neurohospitalist · 2023
    UWUlrike W. Kaunzner
    PMID: 38666287PMCID: PMC11040613DOISenior author

Publications

47 publications

Funding

2 grants

Active

1 grant
  • Co-I
    Treatment of Inflammatory Myelitis and Optic Neuritis with Early versus Rescue Plasma Exchange
    Patient-Centered Outcomes Research Institute · 2025–2027 · via Mayo Clinic
    BPS-2023C3-35505
Completed grants (1)
  • PI
    Clinical Research Training Scholarship in Multiple Sclerosis
    American Academy of Neurology · 2019–2021
    AAN 200412-02

Clinical research

2 studies
Completed & closed trials (2)
  • PI
    An Open-Label, Prospective, Single-arm, Multi-center Study to Assess Disease Activity and Biomarkers of Neuronal Damage in Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab
    PHASE4 · Genentech, Inc. · IRB STUDY CLOSURE (as of 2026)
    Multiple Sclerosis, Relapsing
    NCT04377555
  • PI
    The effect of ocrelizumab on thalamic and cerebellar atrophy in multiple sclerosis patients
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)

External relationships

Ownership

Superlune INC dba Two Moons Health

Advisory/Scientific Board Member

TG Therapeutics, Inc.

Speaker/Lecturer

Med Learning Group

Other

2nd.MD · Alexion Pharmaceuticals, Inc. · Roche Diagnostic Systems · Superlune INC dba Two Moons Health